P28907 (CD38_HUMAN) Homo sapiens (Human)

ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 UniProtKBInterProSTRINGInteractive Modelling

300 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

51 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of human CD38 ECD in complex with UniDab(TM) F11A Heteromer
46-300
98.04EDO;CL;NA;MG;
crystal structure of CD38 in complex with daratumumab Heteromer
48-300
98.37
human CD38 in complex with nanobody MU375 Heteromer
49-300
97.98SO4;GOL;
human CD38 in complex with nanobody MU551 Heteromer
49-296
97.92
human CD38 in complex with nanobody MU1053 Heteromer
49-296
97.95
Crystal Structure of HexaBody-CD38 Fab in complex with CD38 Heteromer
45-291
97.98SO4;GOL;EDO;
Crystal structure of CD38 with a novel CD38-targeting antibody SAR650984 Heteromer
48-287
98.33
Cryo-EM structure of CD38 in complex with FTL004 Heteromer
48-279
100
Crystal structure of human CD38 in complex with the Fab fragment of antibody HB7 Heteromer
50-279
98.26
Crystal structure of daratumumab fab and CD38 complex Heteromer
57-285
100
Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labelinghomo-2-mer45-293
98.39NNR;RIB;
Human CD38 ectodomain bound to a 78c-ADPR adducthomo-2-mer45-283
98.31Q2C;
X-ray structure of human CD38 catalytic domain with 2'-Cl-araNAD+monomer46-300
98.43ROJ;K;PO4;PEG;MPD;PGE;
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
97.22CXR;
Crystal structure of human CD38 extracellular domain, GTP complexmonomer45-296
98.02GTP;
Crystal structure of human CD38 extracellular domain, ara-F-ribose-5'-phosphate/nicotinamide complexmonomer45-296
98.02RF5;NCA;
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
97.62CGR;
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysismonomer45-296
98.02G1R;
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysismonomer45-296
98.02APR;
Catalysis associated conformational changes revealed by human cd38 complexed with a non-hydrolyzabl…monomer45-296
98.02N1C;
Crystal structure of human CD38 extracellular domain, ribose-5'-phosphate intermediate/GTP complexmonomer45-296
98.02RGT;
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
97.62CXR;
Crystal structure of human CD38 complexed with an analog ara-2'F-ADPRmonomer45-296
98.02AVU;
Catalysis associated conformational changes revealed by human CD38 complexed with a non-hydrolyzabl…monomer45-296
97.62N1C;
Crystal structure of human CD38 extracellular domain, NMN complexmonomer45-296
98.02NMN;
Crystal structure of human CD38 extracellular domain E226Q mutant, NMN complexmonomer45-296
97.62NMN;
Crystal structure of human CD38 extracellular domainmonomer45-296
98.02
Crystal structure of human CD38 in complex with compound CZ-50bmonomer45-296
98.0250A;NCA;
Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine NAAPD synthesis and h…monomer45-296
97.62NMN;
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
97.62CXR;
Crystal structure of human CD38 complexed with an analog ribo-2'F-ADP ribosemonomer45-296
98.02AVW;
Crystal structure of human CD38 extracellular domain complexed with a covalent intermediate, ara-F-…monomer45-296
98.02RF5;
Crystal structure of human CD38 in complex with compound CZ-48monomer45-296
98.0248Z;
Crystal structure of human CD38 in complex with compound CZ-46monomer45-296
98.0246Z;
Structural Basis for Formation and Hydrolysis of Calcium Messenger Cyclic ADP-ribose by Human CD38monomer45-296
97.62NGD;
CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose templatemonomer45-296
97.98CVR;
Crystal structure of human CD38: cyclic-ADP-ribosyl synthetase/NAD+ glycohydrolasemonomer46-297
98.41SO4;
Crystal structure of human CD38 in complex with compound CZ-27monomer46-296
98.0127C;
Crystal structure of human CD38 E226Q mutant in complex with NAADPmonomer46-296
97.57DN4;
CD38 structure-based inhibitor design using the N1-cyclic inosine 5'-diphosphate ribose templatemonomer48-296
97.96C8R;
Structural Basis for the Mechanistic Understanding Human CD38 Controlled Multiple Catalysismonomer48-296
97.59NAD;
Structure of a human CD38 mutant complexed with NMNmonomer46-293
97.98NMN;
Crystal Structure of Human CD38 in Complex with 4'-Thioribose NAD+monomer45-292
98.39ZNA;
Crystal structure of human CD38 in complex with hydrolysed compound JMS713monomer50-296
98.35JS2;
Crystal structure of the extracellular domain of human CD38monomer45-291
99.59EPE;
Crystal structure of wild type human CD38 in complex with NAADP and ADPRPmonomer46-291
97.97DVN;
Human CD38 complexed with inhibitor 2 [4-[(2,6-dimethylbenzyl)amino]-2-methylquinoline-8-carboxamid…monomer46-290
97.9241Z;NA7;
Human CD38 complexed with inhibitor 1 [6-fluoro-2-methyl-4-[(2,3,6-trichlorobenzyl)amino]quinoline-…monomer46-288
98.33733;HSX;
HUMAN CD38 ECTODOMAIN BOUND TO COMPOUND 9-ADPR ADDUCTmonomer46-286
98.34X5T;
Dynamic conformations of the CD38-mediated NAD cyclization captured using multi-copy crystallographymonomer46-281
97.44AVU;
Conformational Closure of the Catalytic Site of Human CD38 Induced by Calciummonomer45-279
97.45CA;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6vua.1.Amonomer0.8846-300
K;98.44

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26vua.1.Amonomer0.6746-121
98.70